Exclusive: Anti-aging mRNA therapy biotech acquires Harvard startup’s microvesicle delivery tech
Turn Biotechnologies, a startup developing mRNA therapies to wind back the clock on aging cells has acquired an experimental drug delivery technology from Harvard University and Vesigen Therapeutics, the company exclusively told Endpoints News. ...
Turn Biotechnologies, a startup developing mRNA therapies to wind back the clock on aging cells has acquired an experimental drug delivery technology from Harvard University and Vesigen Therapeutics, the company exclusively told Endpoints News. ...
